Deficiency of ADAMTS13 and thrombotic thrombocytopenic purpura.
Tsai
Han-Mou
HM
D051722:ADAM Proteins; D000071120:ADAMTS13 Protein; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001323:Autoantibodies / Q000276:immunology; D019046:Bone Marrow Neoplasms / Q000175:diagnosis / Q000201:enzymology / Q000556:secondary; D003131:Combined Modality Therapy; D006801:Humans; D008666:Metalloendopeptidases / Q000097:blood; D009382:Neoplasms, Unknown Primary / Q000150:complications / Q000175:diagnosis / Q000201:enzymology / Q000628:therapy; D010951:Plasma Exchange; D011487:Protein Conformation; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000201:enzymology / Q000235:genetics*; D015203:Reproducibility of Results; D013379:Substrate Specificity; D014841:von Willebrand Factor / Q000378:metabolism
D001323:Autoantibodies; D014841:von Willebrand Factor; D051722:ADAM Proteins; D008666:Metalloendopeptidases; D000071120:ADAMTS13 Protein; C099604:ADAMTS13 protein, human